In the lead up to Asian American heritage month, MSNBC’s Katie Phang will sit down with some of this generation's most powerful Asian American and Pacific Islander women.
New data from Bank America hints that maybe everything isn't so great with consumers ahead of the spring shopping season.
The FDA announced feedback regarding using the Liebowitz Social Anxiety Scale (LSAS) as the primary endpoint for future clinical studies designed to evaluate the efficacy of a treatment for the overall control of symptoms of a social anxiety disorder (SAD). SAD is on the rise post-COVID, impacting roughly 23.7 million people across the United States, the company told Benzinga in an email statement. With FDA feedback confirming the acceptable use of the LSAS as a primary efficacy endpoint, Vistag